Page last updated: 2024-11-03

risperidone and Polycystic Ovary Syndrome

risperidone has been researched along with Polycystic Ovary Syndrome in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kopala, LC1
Lewine, R1
Good, KP1
Fluker, M1
Martzke, JS1
Lapointe, JS1
Honer, WG1

Other Studies

1 other study available for risperidone and Polycystic Ovary Syndrome

ArticleYear
Clinical features of schizophrenia in a woman with hyperandrogenism.
    Journal of psychiatry & neuroscience : JPN, 1997, Volume: 22, Issue:1

    Topics: Adult; Antipsychotic Agents; Brain; Estrogens; Female; Humans; Hyperandrogenism; Perceptual Disorder

1997